share_log

中國中藥：交易所通告 - 復牌

TRAD CHI MED: EXCHANGE NOTICE - RESUMPTION OF TRADING

香港交易所 ·  Feb 22 08:34
Summary by Futu AI
中國中藥控股有限公司（證券代號：00570）宣布，其股份將於2024年2月22日上午九時正恢復在香港交易所的買賣。此次復牌是在暫停交易一段時間後進行的，但公告中未提及具體暫停交易的原因及期間。
中國中藥控股有限公司（證券代號：00570）宣布，其股份將於2024年2月22日上午九時正恢復在香港交易所的買賣。此次復牌是在暫停交易一段時間後進行的，但公告中未提及具體暫停交易的原因及期間。
CHINA PHARMACEUTICAL HOLDINGS LIMITED (STOCK CODE: 00570) ANNOUNCED THAT ITS SHARES WILL RESUME TRADING ON THE HONG KONG EXCHANGE AT 9:00 A.M. ON FEBRUARY 22, 2024. This revocation took place after a period of suspension of the transaction, but the announcement did not specify the reason and period for the suspension of the transaction.
CHINA PHARMACEUTICAL HOLDINGS LIMITED (STOCK CODE: 00570) ANNOUNCED THAT ITS SHARES WILL RESUME TRADING ON THE HONG KONG EXCHANGE AT 9:00 A.M. ON FEBRUARY 22, 2024. This revocation took place after a period of suspension of the transaction, but the announcement did not specify the reason and period for the suspension of the transaction.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.